308nm Ultraviolet Light Therapy Device (XWYL-401A, XWYL-403A)
Guangxi Hope Medical Devices Technology Co., Ltd. · Decision date Oct 14, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for 510(k) K262885 on 2026-10-14, covering the 308nm Ultraviolet Light Therapy Device under model designations XWYL-401A and XWYL-403A. The applicant is Guangxi Hope Medical Devices Technology Co., Ltd., listed with an address in Yulin, China. The submission was received 2026-08-17. The record lists product code FTC and specialty as General, Plastic Surgery. Substantial equivalence is a clearance pathway, not premarket approval of the device.
The listed documents do not describe the device's components, its predicate device, or the basis for the equivalence determination. No indications for use, dosing, treatment parameters, or clinical data appear in the available excerpts, and no summary text is included. The relationship between the two model numbers is also unstated. Readers should treat the clearance as a regulatory status record only and consult the FDA 510(k) database entry for scope and labeling details.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262885
- Regulatory pathway
- 510(k) premarket notification
- Product code
- FTC
- Decision code
- SESE
- Decision date
- Oct 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light, Ultraviolet, Dermatological.
- Product code
- FTC
- FDA device class
- 2
FDA decision timeline
K262885 received
Application receipt date recorded by FDA.
K262885 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code FTC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Shijiazhuang Recovery Star Medical Device Co., Ltd. | 510(k) clearance | Oct 5, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Guangxi Hope Medical Devices Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Yulin
Sources and methodology
- Original FDA record: K262885
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records